Loading...
OTCM
ASKPF
Market cap363mUSD
, Last price  
USD
Name

ASKA Pharmaceutical Holdings Co Ltd

Chart & performance

D1W1MN
OTCM:ASKPF chart
P/E
—
P/S
—
EPS
191.05
Vol. 1Y
—
Shs. 5Y
0.01%
Rev. 5Y
5.21%
Div Yld LY
—
Div Yld TTM
—
Revenues
71.13b
+10.90%
30,301,391,00030,170,000,00030,422,000,00035,784,000,00045,849,000,00040,637,000,00040,963,000,00039,501,000,00042,907,000,00043,215,000,00048,527,000,00048,944,000,00046,705,000,00052,542,000,00055,181,000,00056,607,000,00060,461,000,00062,843,000,00064,139,000,00071,127,000,000
Net income
5.43b
+6.35%
969,658,0003,513,000,000600,000,00093,000,000-790,000,0007,000,0001,114,000,000495,000,0001,193,000,000701,000,0002,944,000,0002,388,000,0001,744,000,000649,000,0002,713,000,0004,290,000,0004,238,000,0007,545,000,0005,101,000,0005,425,000,000
CFO
6.30b
+153.64%
1,361,826,0006,014,000,000-215,000,0002,667,000,0003,558,000,000-2,514,000,0003,869,000,0002,616,000,0005,709,000,000-1,349,000,00012,063,000,00076,000,0002,504,000,000-492,000,0006,541,000,0002,842,000,0003,351,000,0001,486,000,0002,485,000,0006,303,000,000

Notes

No notes on this company yet
Write a private note on this company, for your eyes only
Add note

Profile

ASKA Pharmaceutical Holdings Co.,Ltd. is a Japanese enterprise that operates through its subsidiaries in three primary areas: pharmaceuticals, animal healthcare, and hormone testing services. The company's pharmaceutical division is dedicated to the research, development, production, and commercialization of medications, with a specific focus on endocrinology, obstetrics and gynecology, and urology. Within its animal health segment, ASKA manufactures, sells, imports, and exports a broad spectrum of veterinary products, such as medicines, medical equipment, animal feed and supplements, laboratory reagents, agricultural chemicals, industrial chemicals, hygiene products, and food items along with their raw materials. Beyond these activities, the company also performs clinical and biological testing and offers medical devices. Founded in 1920, ASKA Pharmaceutical Holdings Co.,Ltd. is headquartered in Tokyo, Japan.

Key people

Takashi Yamaguchi
Chairman of the Board, Representative Director · since 2025
Sohta Yamaguchi
President, Representative Director · since 2025
Maiko Mori
Managing Executive Officer, Director · since 2022
Kiyohiko Tamura
Managing Executive Officer, Chief Director of Group Business Administration · since 2022
Fumiyoshi Yamaguchi
Managing Executive Officer, President of Subsidiary, Director · since 2022
Tomohito Nagao
Executive Officer · since 2025
Junichi Saito
Executive Officer, President of Subsidiary · since 2022
Seiko Kato
Director · since 2025
Atsushi Maruo
Senior Managing Director, Representative Director · since 2021
Minoru Awabayashi
Independent Director · since 2023
Yasuji Enokido
Independent Director · since 2023
Kanae Karita
Independent Director · since 2024
URL
https://www.aska-pharma-hd.co.jp
IPO date
Apr 01, 2021
Employees
747
Domiciled in
JP
Incorporated in
JP

Valuation

Title
JPY in thousands, except ratios and share amounts
FYFYFYFYFYFYFYFYFYFY
2026‑032025‑032024‑032023‑032022‑032021‑032020‑032019‑032018‑032017‑03
Income
Revenues
Cost of revenue
Unusual Expense (Income)
NOPBT
NOPBT Margin
Operating Taxes
Tax Rate
NOPAT
Net income
Dividends
Dividend yield
Proceeds from repurchase of equity
BB yield
Debt
Debt current
Long-term debt
Deferred revenue
Other long-term liabilities
Net debt
Cash flow
Cash from operating activities
CAPEX
Cash from investing activities
Cash from financing activities
FCF
Balance
Cash
Long term investments
Excess cash
Stockholders' equity
Invested Capital
ROIC
ROCE
EV
Common stock shares outstanding
Price
Market cap
EV
EBITDA
EV/EBITDA
Interest
Interest/NOPBT